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Abstract
Background:  Flecainide is an antiarrhythmic agent which is being used increasingly for the
management of super-ventricular arrhythmias. Overdose with flecainide is frequently fatal with
mortality reported as high as 22% due to arrhythmias, myocardial depression and conduction
defects leading to electro-mechanical dissociation and asytole. Supportive measures are often
required during the case and previously have included inotropes, extracorporeal membrane
oxygenation and cardiopulmonary bypass.
Case presentation: A 47 year old lady presented to the emergency department with a four hour
history of severe central chest pain. Her ECG showed atrial fibrillation and broad QRS complexes
with a sine wave appearance. She had a past history of paroxysmal atrial fibrillation and significant
psychiatric history. Following thrombolysis for a presumed myocardial infarction she developed
cardiogenic shock with severely impaired left ventricular function. An intra-aortic balloon pump
was inserted and coronary angiography demonstrated normal coronary arteries. With inotropic
support she improved over 48 hours, with both her QRS duration and left ventricular function
returning to normal. Biochemical testing following her discharge demonstrated significantly
elevated levels of flecainide.
Conclusion: The use of an intra-aortic balloon pump is a useful supportive measure during the
acute phase of flecainide overdose associated with severe myocardial depression.
Background
Flecainide is an increasingly used class 1C antiarrhythmic
drug used for the management of both supra-ventricular
and ventricular arrhythmias. It causes rate-dependent
slowing of the rapid sodium channel slowing phase 0 of
depolarisation [1] and in high doses inhibits the slow cal-
cium channel. Flecainide also slows conduction in all car-
diac fibres, increasing conduction times in the atria,
ventricles, atrio-ventricular node and His-Purkinje system
and can cause myocardial depression.
Case presentation
A 47 year old lady presented to the emergency department
with a four hour history of severe central chest pain radi-
ating to the neck. She had a significant psychiatric history
with multiple episodes of self harm and had previously
been hospitalised with behavioural problems. The patient
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had a history of multiple admissions with cardiac sound-
ing chest pain, all with normal ECG and cardiac troponin
levels. An outpatient stress nuclear perfusion scan was
normal. The patient also had a history of arterial hyper-
tension and paroxysmal atrial fibrillation and was man-
aged on a combination of amitriptyline, losartan,
amlodipine and flecainide. During this admission she
repeatedly denied taking an overdose.
On admission to the emergency room the patient was
unresponsive with a GCS of 6. She rapidly regained con-
sciousness but remained slightly drowsy. Pupil response
was normal. Her pulse was 70 bpm and blood pressure
60/40 mmHg. The 12-lead ECG (figure 1) revealed atrial
fibrillation with a broad QRS complex (320 ms) with a
sine wave appearance. An ECG had been performed 4
weeks previously and was normal. She had normal serum
potassium (4.1 mmol/l). The presentation with chest pain
led to a presumptive diagnosis of an acute myocardial inf-
arction and she was treated with thrombolysis with intra-
venous alteplase. Ten minutes later there was a significant
change in her ECG (figure 2). Inotropic support was insti-
tuted with dobutamine and subsequently with adrenaline
to maintain her blood pressure. She remained hypoten-
sive with poor urine output and was transferred to the
regional cardiothoracic unit for further management.
Blood was taken for paracetamol, salicylate levels which
were normal. Flecanide levels were requested. Blood gases
showed pH 7.37, pCO2 6.1kPa, pO2 11.7, bicarbonate
25.3 mmol/l
On arrival at our institution, transthoracic echocardiogra-
phy revealed global moderate impairment of left ventricu-
lar function. Emergency coronary angiography was
performed demonstrating normal epicardial coronary
arteries and left ventriculography confirmed the echocar-
diography findings. An intra-aortic balloon pump was
inserted with a rapid improvement in haemodynamics.
Over the following 48 hours the patient was weaned from
the inotropes and the intra-aortic balloon pump was
removed. During this period her QRS duration gradually
returned to normal (figure 3) with left axis deviation and
first degree heart block (which was present 12 months
previously). Repeat echocardiography demonstrated nor-
mal left ventricular function.
Following discharge her flecanide levels were returned as
2340 µg/l (normal therapeutic range 200–700 µg/l) at 24
hours post admission.
Discussion
The mortality of overdose with class 1C agents has been
reported as high as 22% compared to less than 1% for all
drug overdoses [2]. In such cases fatal outcome is often
related to the progression of conductions disturbance to
electromechanical dissociation and asytole. Although less
common, ventricular arrhythmias may occur and are fre-
quently unresponsive to electrical cardioversion [3].
Other features may occur due to impaired tissue perfusion
including hypoxia, metabolic acidosis, coma and convul-
sions. Hypotension can occur within minutes of a signifi-
cant flecainide overdose, and subsequent reduction in
hepatic and renal flow leading to prolongation of the
duration of toxicity.
The proarrhythmic effects of flecanide may be related to
flecainide promoting re-entry in ventricular tissue [4].
Worsening of existing ventricular arrhythmias or the onset
of new ones can occur in up to 30% of patients [5]. Flecai-
nide depresses cardiac contractility especially in patients
with underlying impairment of function.
The management of an overdose includes supportive
measures and specific pharmacological agents. The bene-
fit of activated charcoal is uncertain but this may be con-
sidered within the first hour of ingestion [8].
12-lead ECG on admission Figure 1
12-lead ECG on admission.
12-lead ECG after thrombolysis Figure 2
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Hemodynamic support may be required including the
fluid replacement, inotropes and an intra-aortic balloon
pump as in this case. Both extracorporeal membrane oxy-
genation and cardiopulmonary bypass have been used in
cases of severe overdose [6,7] but the use of intra-aortic
balloon pump has not previously been described.
Sodium bicarbonate is recommended for a metabolic aci-
dosis that persists despite correction of hypoxia and ade-
quate fluid resuscitation [8]. Following administration of
intravenous sodium bicarbonate QRS narrowing has been
reported and also termination of ventricular tachycardia.
[9]. Ventricular arrhythmias may be difficult to cardiovert
electrically and both lidocaine and amiodarone have been
used successfully in such cases [3,10]. Cardiac pacing may
be required but ventricular capture may be poor [3].
Conclusion
Flecainide overdose is frequently fatal and supportive
measures including the use of intra-aortic balloon pump-
ing may be required for severe myocardial depression that
may occur during the acute phase.
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12-lead ECG after treatment Figure 3
12-lead ECG after treatment.